The economics of medication safety
Improving medication safety through collective, real-time learning
Poor medication practices and inadequate system infrastructure—resulting in poor adherence,
medication-related harms, and medication errors—too often results in patient harm.
As many as 1 in 10 hospitalizations in OECD countries may be caused by a medication-related
event and as many one in five inpatients experience medication-related harms during
hospitalization. Together, costs from avoidable admissions due to medication-related
events and added length of stay due to preventable hospital-acquired medication-related
harms total over USD 54 billion in OECD countries. This report includes four components;
it 1) assess the human impact and economic costs of medication safety events in OECD
countries, 2) explores opportunities to improve prescribing practices 3) examines
the state-of-the art in systems and policies for improving medication safety, and
4) provides recommendations for improving medication safety at the national level.
Published on September 14, 2022Also available in: German
In series:OECD Health Working Papersview more titles